Previous 10 | Next 10 |
2023-07-12 10:03:23 ET Gainers: Healthcare Triangle ( HCTI ) +183% . Recursion Pharmaceuticals ( RXRX ) +71% . Cadrenal Therapeutics ( CVKD ) +43% . Liminal BioSciences ( LMNL ) +40% . Eloxx Pharmaceuticals ( ELOX ) +29% . L...
2023-07-12 09:22:29 ET Recursion ( NASDAQ: RXRX ) said on Wednesday that it had secured a $50M investment from Nvidia ( NVDA ), which was implemented as a private investment in public equity. RXRX shares more than doubled to $15.53 in premarket trading. "Recursion also...
SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced a $50 million investment by NVIDIA , which was executed as a private invest...
2023-06-29 05:13:37 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Longevity efforts are forefront of the news cycle today, due in large part to recent coverage of tech billionaire Bryan Johnson’s unique strategy to delay aging . This has investors ...
2023-06-27 17:26:51 ET Gainers: Geospace Technologies ( GEOS ) +7% . AeroVironment ( AVAV ) +6% . Codexis ( CDXS ) +5% . Recursion Pharmaceuticals ( RXRX ) +3% . CECO Environmental ( CECO ) +3% . Losers: AST SpaceMo...
TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today celebrated the opening of its 28,000 square foot Toronto site, which will serve as the headquarters for Recursion Canada. The n...
2023-06-16 17:39:00 ET Gainers: Kezar Life Sciences ( NASDAQ: KZR ) +6% . Telos Corporation ( TLS ) +4% . Dyne Therapeutics ( DYN ) +4% . Recursion Pharmaceuticals ( RXRX ) +4% . Berry Corporation ( BRY ) +4% . Losers: ...
2023-06-14 00:21:10 ET Summary Recursion Pharmaceuticals presents a compelling investment opportunity due to its AI-driven drug discovery platform, solid financials, and diverse pipeline, setting it apart from competitors like AstraZeneca, Novartis, Roche, and Biogen. The company'...
SALT LAKE CITY, June 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the full enrollment of its Phase 2 SYCAMORE clinical trial evaluating REC-994, a potentially first-in-class, o...
2023-05-31 18:37:35 ET Summary Recursion completed one of biotech's biggest ever IPO's in 2020, raising >$500m. The company wants to "decode biology," which strikes me as a little too ambitious. The business model is all about attracting biotech and pharma clients and earni...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...